The Company
Liposomal systems designed for controlled scale and reproducibility.
Operating from a fully integrated UK facility, GMPriority Pharma combines controlled manufacturing environments, scientific oversight and defined quality frameworks to support consistent commercial-scale supply.
We partner with brands, formulators and ingredient companies who require reliable liposomal manufacture within regulated environments and confidence that what is developed can be produced, scaled and supplied without compromise.
Our Approach
GMPriority Pharma develops and manufactures liposomal systems within a delivery-led framework designed to support stability, process control and commercial-scale production.
Rather than treating delivery as a downstream adjustment, formulation design and processing parameters are defined from the outset, aligning lipid architecture with particle behaviour, stability requirements and manufacturing constraints.
This enables consistent output across white label products, contract manufacturing programmes and bulk ingredient supply, while supporting reliable scale-up and long-term supply continuity.
Scientific direction is led by Professor Mohammad Najlah, Chief Scientist and Co-Founder.
Professor Najlah’s expertise in lipid-based delivery systems and translational formulation science underpins GMPriority Pharma’s approach to formulation design, process development and commercial manufacture.
His work focuses on how delivery systems behave under real formulation, processing and scale-up conditions, ensuring that development decisions are aligned with manufacturing reality from the outset.
This scientific leadership is supported by a multidisciplinary team spanning formulation science, analytical characterisation and production, operating within an integrated environment that connects research, development and manufacturing.
Scientific Direction & Leadership
Why Delivery-First Matters
GMPriority Pharma was established on a simple observation: successful ingredient and product development depends not only on the active, but on how it is formulated, processed and scaled.
From the outset, we focused on integrating formulation expertise with controlled manufacturing environments and defined quality frameworks, aligning development decisions with production reality.
Rather than treating delivery as a downstream optimisation, we design liposomal systems with manufacturing constraints, stability requirements and scale-up considerations defined from the outset.
This approach supports consistent performance,
predictable scale-up and long-term commercial supply.
Built on Applied Delivery Science
GMPriority Pharma’s expertise is grounded in applied work with lipid-based and liposomal systems, including nanoencapsulated formats developed for controlled manufacture.
Our focus is on how these systems are formulated, characterised and produced within defined processing and manufacturing environments, from early development through to commercial-scale output.
Core areas of expertise include:
- Lipid and liposomal formulation design
- Structural and physicochemical characterisation, including particle size distribution and dispersion behaviour
- Process development to support controlled scale-up and batch production
This work is supported through collaboration with academic and research institutions, ensuring that delivery systems are informed by current scientific understanding and validated under real-world conditions.
Scientific expertise at GMPriority Pharma is applied with a clear objective: to support manufacturing discipline, product integrity and reliable long-term commercial supply.
Built for real-world manufacture
GMPriority Pharma integrates development and manufacturing within a single operational framework, ensuring delivery systems are designed with production constraints, regulatory requirements and scale in mind.
From early formulation through to commercial output, development decisions are aligned with how products will be manufactured, transferred and supplied.
From development to commercial scale
Our approach supports:
- Development informed by real manufacturing conditions
- Early identification of scale-dependent risks
- Processes aligned with regulatory frameworks
- Consistent execution across ingredient types and formats
A manufacturing partner, not just a supplier
GMPriority Pharma supports partners beyond initial development, providing structured manufacturing capability designed for reliable commercial supply.
Our focus is on reducing technical risk, maintaining process integrity and supporting long-term production continuity.
Advanced delivery expertise
Scalable manufacturing capability
Contact us
Whether developing a new formulation, scaling an existing system or sourcing liposomal ingredients, our team works with partners to deliver structured, manufacturable solutions.
